Voluntary Announcement of Sihuan Pharmaceutical co., LTD. - Sihuan Pharmaceutical Co., Ltd. signed a cooperation agreement with Chongqing Paijin Biotechnology Co., Ltd. on the development of "insulin project"
Source:Caihua Think Tank network
|
Author:pro954f45
|
Published time: 2014-08-13
|
699 Views
|
Share:
Sihuan Pharmaceutical Holding Group Co., LTD. (the "Company" or "Sihuan Pharmaceutical", together with its subsidiaries, collectively referred to as the "Group") Sihuan pharmaceutical in August 2014, 12 wholly owned subsidiary of jilin sihuan pharmaceutical co., LTD. (" jilin sihuan ") and chongqing sent gold biotechnology co., LTD. (" chongqing biological technology ") is five related to insulin preparations series valley (recombinant insulin raw materials and preparations, restructuring the door winter insulin preparations, restructuring the common insulin raw materials and raw materials and the mixture, restructuring, valley insulin door winter, the mixture normal insulin door winter) signed a cooperation agreement, the group will get all the five products' property rights and management rights, To this end, a total of RMB 66 million will be paid to Chongqing Paykin Biotechnology Co., LTD., which will be paid in stages according to the development process of each project. According to the cooperation agreement, after the product goes on the market, Chongqing Biotechnology will receive a commission of the product sales revenue as income, which is about 2%-3% of the sales revenue, and the withdrawal period is 8-12 years.
